Cargando…
1772P Impact assessment of SARS-CoV-2 testing on cancer patients undergoing immunosuppressive treatment
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506417/ http://dx.doi.org/10.1016/j.annonc.2020.08.1836 |
| _version_ | 1783585013649899520 |
|---|---|
| author | Tavares, A. Magalhães, D. Soares, A. Laranjinha, J. Mesquita, A. Duarte, F. Abreu, R.C. Magalhães, H. Braga, F. Sottomayor, C. Salgado, M. |
| author_facet | Tavares, A. Magalhães, D. Soares, A. Laranjinha, J. Mesquita, A. Duarte, F. Abreu, R.C. Magalhães, H. Braga, F. Sottomayor, C. Salgado, M. |
| author_sort | Tavares, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7506417 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75064172020-09-23 1772P Impact assessment of SARS-CoV-2 testing on cancer patients undergoing immunosuppressive treatment Tavares, A. Magalhães, D. Soares, A. Laranjinha, J. Mesquita, A. Duarte, F. Abreu, R.C. Magalhães, H. Braga, F. Sottomayor, C. Salgado, M. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2020-09 2020-09-22 /pmc/articles/PMC7506417/ http://dx.doi.org/10.1016/j.annonc.2020.08.1836 Text en Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Tavares, A. Magalhães, D. Soares, A. Laranjinha, J. Mesquita, A. Duarte, F. Abreu, R.C. Magalhães, H. Braga, F. Sottomayor, C. Salgado, M. 1772P Impact assessment of SARS-CoV-2 testing on cancer patients undergoing immunosuppressive treatment |
| title | 1772P Impact assessment of SARS-CoV-2 testing on cancer patients undergoing immunosuppressive treatment |
| title_full | 1772P Impact assessment of SARS-CoV-2 testing on cancer patients undergoing immunosuppressive treatment |
| title_fullStr | 1772P Impact assessment of SARS-CoV-2 testing on cancer patients undergoing immunosuppressive treatment |
| title_full_unstemmed | 1772P Impact assessment of SARS-CoV-2 testing on cancer patients undergoing immunosuppressive treatment |
| title_short | 1772P Impact assessment of SARS-CoV-2 testing on cancer patients undergoing immunosuppressive treatment |
| title_sort | 1772p impact assessment of sars-cov-2 testing on cancer patients undergoing immunosuppressive treatment |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506417/ http://dx.doi.org/10.1016/j.annonc.2020.08.1836 |
| work_keys_str_mv | AT tavaresa 1772pimpactassessmentofsarscov2testingoncancerpatientsundergoingimmunosuppressivetreatment AT magalhaesd 1772pimpactassessmentofsarscov2testingoncancerpatientsundergoingimmunosuppressivetreatment AT soaresa 1772pimpactassessmentofsarscov2testingoncancerpatientsundergoingimmunosuppressivetreatment AT laranjinhaj 1772pimpactassessmentofsarscov2testingoncancerpatientsundergoingimmunosuppressivetreatment AT mesquitaa 1772pimpactassessmentofsarscov2testingoncancerpatientsundergoingimmunosuppressivetreatment AT duartef 1772pimpactassessmentofsarscov2testingoncancerpatientsundergoingimmunosuppressivetreatment AT abreurc 1772pimpactassessmentofsarscov2testingoncancerpatientsundergoingimmunosuppressivetreatment AT magalhaesh 1772pimpactassessmentofsarscov2testingoncancerpatientsundergoingimmunosuppressivetreatment AT bragaf 1772pimpactassessmentofsarscov2testingoncancerpatientsundergoingimmunosuppressivetreatment AT sottomayorc 1772pimpactassessmentofsarscov2testingoncancerpatientsundergoingimmunosuppressivetreatment AT salgadom 1772pimpactassessmentofsarscov2testingoncancerpatientsundergoingimmunosuppressivetreatment |